相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease
Michael M. Vickers et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Nigel B. Jamieson et al.
CLINICAL CANCER RESEARCH (2012)
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
Niels H. H. Heegaard et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy
Qi Long et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
Kenoki Ohuchida et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma
Linwah Yip et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome
Zhuang Zuo et al.
BLOOD (2011)
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer
M. Kalimutho et al.
BRITISH JOURNAL OF CANCER (2011)
MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML
Yin Xiong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
Francesca M. Buffa et al.
CANCER RESEARCH (2011)
Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis
Pengxu Qian et al.
CANCER RESEARCH (2011)
MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets
Deepak Abraham et al.
CLINICAL CANCER RESEARCH (2011)
A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Xiaogang Tan et al.
CLINICAL CANCER RESEARCH (2011)
Clinical Significance of miR-146a in Gastric Cancer Cases
Ryunosuke Kogo et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Alvaro J. Alencar et al.
CLINICAL CANCER RESEARCH (2011)
The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma
Tengfei Zhang et al.
CLINICAL SCIENCE (2011)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer
William C. S. Cho
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance
William C. S. Cho
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Molecular diagnostics for monitoring and predicting therapeutic effect in cancer
William C. S. Cho
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
Francoise Rothe et al.
PLOS ONE (2011)
Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma
Fabricio F. Costa et al.
PLOS ONE (2011)
MicroRNA 92a-2 A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer
Aarati R. Ranade et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
分享论文
